• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症纳米免疫疗法:抗击癌症的新型有前途的武器。

Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer.

机构信息

Department of Medical Biochemistry and Molecular Biology, and Immunology, School of Medicine, University of Seville, 41009 Seville, Spain.

Institute of Biomedicine of Seville, IBiS, 41013 Seville, Spain.

出版信息

Int J Mol Sci. 2024 Jan 18;25(2):1195. doi: 10.3390/ijms25021195.

DOI:10.3390/ijms25021195
PMID:38256268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10816838/
Abstract

Cancer is a complex disease that, despite advances in treatment and the greater understanding of the tumor biology until today, continues to be a prevalent and lethal disease. Chemotherapy, radiotherapy, and surgery are the conventional treatments, which have increased the survival for cancer patients. However, the complexity of this disease together with the persistent problems due to tumor progression and recurrence, drug resistance, or side effects of therapy make it necessary to explore new strategies that address the challenges to obtain a positive response. One important point is that tumor cells can interact with the microenvironment, promoting proliferation, dissemination, and immune evasion. Therefore, immunotherapy has emerged as a novel therapy based on the modulation of the immune system for combating cancer, as reflected in the promising results both in preclinical studies and clinical trials obtained. In order to enhance the immune response, the combination of immunotherapy with nanoparticles has been conducted, improving the access of immune cells to the tumor, antigen presentation, as well as the induction of persistent immune responses. Therefore, nanomedicine holds an enormous potential to enhance the efficacy of cancer immunotherapy. Here, we review the most recent advances in specific molecular and cellular immunotherapy and in nano-immunotherapy against cancer in the light of the latest published preclinical studies and clinical trials.

摘要

癌症是一种复杂的疾病,尽管在治疗和对肿瘤生物学的理解方面取得了进展,但直到今天,它仍然是一种普遍存在且致命的疾病。化疗、放疗和手术是传统的治疗方法,这些方法提高了癌症患者的生存率。然而,这种疾病的复杂性,以及由于肿瘤进展和复发、耐药性或治疗副作用而持续存在的问题,使得有必要探索新的策略来应对挑战,以获得积极的反应。一个重要的观点是,肿瘤细胞可以与微环境相互作用,促进增殖、扩散和免疫逃逸。因此,免疫疗法已经作为一种新的治疗方法出现,基于免疫系统的调节来对抗癌症,这在临床前研究和临床试验中都取得了有希望的结果。为了增强免疫反应,已经进行了免疫疗法与纳米颗粒的联合治疗,改善了免疫细胞进入肿瘤、抗原呈递以及持续免疫反应的诱导。因此,纳米医学在增强癌症免疫疗法的疗效方面具有巨大的潜力。在这里,我们根据最新发表的临床前研究和临床试验,综述了针对癌症的特定分子和细胞免疫疗法以及纳米免疫疗法的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3981/10816838/ec105564415b/ijms-25-01195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3981/10816838/41d3f0975e68/ijms-25-01195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3981/10816838/ec105564415b/ijms-25-01195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3981/10816838/41d3f0975e68/ijms-25-01195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3981/10816838/ec105564415b/ijms-25-01195-g002.jpg

相似文献

1
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer.癌症纳米免疫疗法:抗击癌症的新型有前途的武器。
Int J Mol Sci. 2024 Jan 18;25(2):1195. doi: 10.3390/ijms25021195.
2
Combining Nanomedicine and Immunotherapy.纳米医学与免疫疗法的联合应用。
Acc Chem Res. 2019 Jun 18;52(6):1543-1554. doi: 10.1021/acs.accounts.9b00148. Epub 2019 May 23.
3
Improved cancer immunotherapy strategies by nanomedicine.纳米医学改善癌症免疫疗法策略。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1873. doi: 10.1002/wnan.1873. Epub 2022 Dec 28.
4
Exosomes: Powerful weapon for cancer nano-immunoengineering.外泌体:癌症纳米免疫工程的强大武器。
Biochem Pharmacol. 2021 Apr;186:114487. doi: 10.1016/j.bcp.2021.114487. Epub 2021 Feb 27.
5
Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.将纳米医学与免疫检查点治疗相结合用于癌症免疫治疗。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Jan;14(1):e1739. doi: 10.1002/wnan.1739. Epub 2021 Jul 22.
6
Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.纳米生物材料调控肿瘤免疫循环和肿瘤微环境增强肿瘤免疫治疗
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jul;12(4):e1612. doi: 10.1002/wnan.1612. Epub 2020 Mar 1.
7
Nanomedicine enables spatiotemporally regulating macrophage-based cancer immunotherapy.纳米医学使基于巨噬细胞的癌症免疫治疗得以实现时空调节。
Biomaterials. 2021 Jan;268:120552. doi: 10.1016/j.biomaterials.2020.120552. Epub 2020 Nov 28.
8
Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.肿瘤相关巨噬细胞、纳米医学与成像:癌症免疫治疗未来的成功轴心
Immunotherapy. 2017 Sep;9(10):819-835. doi: 10.2217/imt-2017-0041.
9
Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.基于纳米颗粒的纳米药物促进癌症免疫治疗:最新进展与未来方向。
Small. 2019 Aug;15(32):e1900262. doi: 10.1002/smll.201900262. Epub 2019 Mar 25.
10
Cancer nanomedicine meets immunotherapy: opportunities and challenges.癌症纳米医学与免疫治疗的结合:机遇与挑战。
Acta Pharmacol Sin. 2020 Jul;41(7):954-958. doi: 10.1038/s41401-020-0448-9. Epub 2020 Jun 17.

引用本文的文献

1
Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation.白血病治疗中的纳米技术:革新靶向药物递送与免疫调节
Clin Exp Med. 2025 May 17;25(1):166. doi: 10.1007/s10238-025-01686-z.
2
Immunomodulatory nanoplatforms with multiple mechanisms of action in cancer treatment.在癌症治疗中具有多种作用机制的免疫调节纳米平台。
Nanomedicine (Lond). 2025 Jun;20(11):1321-1338. doi: 10.1080/17435889.2025.2500906. Epub 2025 May 7.
3
Nanocarriers for cutting-edge cancer immunotherapies.用于前沿癌症免疫疗法的纳米载体。

本文引用的文献

1
The Evolving Landscape of Immunotherapy in Uterine Cancer: A Comprehensive Review.子宫癌免疫治疗的发展态势:全面综述
Life (Basel). 2023 Jul 3;13(7):1502. doi: 10.3390/life13071502.
2
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.CFI-402257,一种 TTK 抑制剂,能有效抑制肝癌。
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2119514119. doi: 10.1073/pnas.2119514119. Epub 2022 Aug 1.
3
Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities.
J Transl Med. 2025 Apr 16;23(1):447. doi: 10.1186/s12967-025-06435-0.
4
Metformin and its Nanoformulations in Cancer Prevention and Therapy.二甲双胍及其纳米制剂在癌症预防与治疗中的应用
Curr Pharm Des. 2025 Apr 8. doi: 10.2174/0113816128367242250214052019.
5
CD36 as a Therapeutic Target in Tumor Microenvironment and Lipid Metabolism.CD36作为肿瘤微环境和脂质代谢中的治疗靶点
Anticancer Agents Med Chem. 2025;25(7):447-459. doi: 10.2174/0118715206353634241111113338.
6
Global research and current trends on nanotherapy in lung cancer research: a bibliometric analysis of 20 years.肺癌研究中纳米疗法的全球研究与当前趋势:二十年的文献计量分析
Discov Oncol. 2024 Oct 9;15(1):539. doi: 10.1007/s12672-024-01332-2.
嵌合抗原受体 (CAR)-T 细胞免疫疗法治疗胸部恶性肿瘤:挑战与机遇。
Front Immunol. 2022 Jul 14;13:871661. doi: 10.3389/fimmu.2022.871661. eCollection 2022.
4
Radiotherapy combined with immunotherapy: the dawn of cancer treatment.放疗联合免疫治疗:癌症治疗的曙光。
Signal Transduct Target Ther. 2022 Jul 29;7(1):258. doi: 10.1038/s41392-022-01102-y.
5
Current approaches of nanomedicines in the market and various stage of clinical translation.市场上纳米药物的当前方法以及临床转化的各个阶段。
Acta Pharm Sin B. 2022 Jul;12(7):3028-3048. doi: 10.1016/j.apsb.2022.02.025. Epub 2022 Mar 1.
6
Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms.利用 EPR 效应和其他靶向机制增强药物递送至实体瘤的策略。
Adv Drug Deliv Rev. 2022 Sep;188:114449. doi: 10.1016/j.addr.2022.114449. Epub 2022 Jul 11.
7
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.NY-ESO-1 特异性重定向 T 细胞与内源性 TCR 敲低介导肿瘤反应和细胞因子释放综合征。
J Immunother Cancer. 2022 Jun;10(6). doi: 10.1136/jitc-2021-003811.
8
Nanodrugs Targeting T Cells in Tumor Therapy.纳米药物靶向肿瘤治疗中的 T 细胞。
Front Immunol. 2022 May 25;13:912594. doi: 10.3389/fimmu.2022.912594. eCollection 2022.
9
Design of smart nanomedicines for effective cancer treatment.智能纳米药物设计用于有效治疗癌症。
Int J Pharm. 2022 Jun 10;621:121791. doi: 10.1016/j.ijpharm.2022.121791. Epub 2022 May 4.
10
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics.淋巴瘤中的肿瘤免疫微环境:聚焦表观遗传学
Cancers (Basel). 2022 Mar 13;14(6):1469. doi: 10.3390/cancers14061469.